fda bans tirzepatide FDA's decision creates uncertainty for patients—and leads to a lawsuit FDA officials warn of fake

En la semana 52, los participantes que cambiaron de semaglutida DMT a orforglipron mantuvieron toda su prdida de peso previamente lograda excepto 0,9 kg, mientras que aquellos que cambiaron de tirzepatida DMT a orforglipron mantuvieron toda su prdida de peso excepto 5,0 kg

doi: Cell Rep

Due to the lack of targeted research, its not possible to definitively determine whether GLP-1 drugs are completely safe or unsafe for those with hemophilia

16 Vestibular Migraine Vestibular migraine is managed with similar treatments used for migraine headaches, although their efficacy for vestibular migraine is not well-studied

Compared to usual care, participants who used GLP-1RAs had a lower risk of: substance use and psychotic disorders seizures neurocognitive disorders including Alzheimers disease and dementia infectious illnesses several respiratory conditions coagulation and cardiometabolic disorders, including deep vein thrombosis, pulmonary embolism, stroke, cardiac arrest, heart failure and myocardial infarction